MOLEBRIDGE PRACTICE
3 CANNONSIDE, FETCHAM, LEATHERHEADSMO PREV
The percentage of patients with a hypertension, asthma, COPD, stroke or CHD who, when asked reported smoking.
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
SMO PREV | 2007 | 210 | 1391 | 15.1% | |
SMO PREV | 2008 | 199 | 1387 | 14.3% | |
SMO PREV | 2009 | 241 | 1470 | 16.4% | |
SMO PREV | 2010 | 233 | 1522 | 15.3% | |
SMO Prev | 2011 | 218 | 1513 | 14.4% | |
SMO Prev | 2012 | 215 | 1493 | 14.4% | |
SMO Prev | 2013 | 206 | 1501 | 13.7% | |
SMO Prev | 2015 | 189 | 1562 | 12.1% | |
SMO Prev | 2016 | 183 | 1524 | 12.0% | |
SMO Prev | 2017 | 201 | 1487 | 13.5% | |
SMO Prev | 2018 | 185 | 1400 | 13.2% | |
SMO Prev | 2019 | 153 | 1258 | 12.2% | |
SMO Prev | 2020 | 171 | 1286 | 13.3% | |
SMO Prev | 2021 | 171 | 1336 | 12.8% | |
SMO Prev | 2022 | 175 | 1376 | 12.7% | |
SMO Prev | 2023 | 168 | 1426 | 11.8% |